Foralumab Nasal

Foralumab · Tiziana Life Sciences Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Foralumab Nasal, covering 2025-06-06 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA) [Phase 2]